Achyut Healthcare Limited (ACHYUT.BO)
INR 3.55
(-1.11%)
INR 3.55
(-1.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 61.36 Million INR | 141.36% |
| 2022 | 25.42 Million INR | -28.91% |
| 2021 | 35.76 Million INR | 1211.59% |
| 2020 | 2.72 Million INR | -18.38% |
| 2019 | 3.34 Million INR | -49.86% |
| 2018 | 6.66 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 21.26 Million INR | 0.0% |
| 2023 Q1 | 7.41 Million INR | -8.28% |
| 2023 Q4 | 46.54 Million INR | 100.0% |
| 2023 Q2 | 14.82 Million INR | 100.0% |
| 2023 FY | 61.36 Million INR | 141.36% |
| 2023 Q3 | 23.27 Million INR | 56.95% |
| 2022 Q3 | 4.04 Million INR | -57.16% |
| 2022 Q2 | 9.43 Million INR | 0.0% |
| 2022 FY | 25.42 Million INR | -28.91% |
| 2022 Q1 | 9.43 Million INR | -29.43% |
| 2022 Q4 | 8.08 Million INR | 99.98% |
| 2021 Q1 | 13.56 Million INR | 0.0% |
| 2021 FY | 35.76 Million INR | 1211.59% |
| 2021 Q4 | 13.37 Million INR | 100.01% |
| 2021 Q3 | 6.68 Million INR | -75.35% |
| 2021 Q2 | 27.12 Million INR | 100.0% |
| 2020 FY | 2.72 Million INR | -18.38% |
| 2019 FY | 3.34 Million INR | -49.86% |
| 2018 FY | 6.66 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alkem Laboratories Limited | 126.67 Billion INR | 99.952% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | 98.543% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 99.9% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 99.526% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 99.979% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | 84.671% |
| Eris Lifesciences Limited | 20.09 Billion INR | 99.695% |
| FDC Limited | 19.42 Billion INR | 99.684% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 99.731% |
| Ipca Laboratories Limited | 76.22 Billion INR | 99.919% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | 97.059% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | 87.829% |
| Laurus Labs Limited | 50.01 Billion INR | 99.877% |
| Lupin Limited | 200.1 Billion INR | 99.969% |
| Medicamen Biotech Limited | 1.79 Billion INR | 96.577% |
| Medico Remedies Limited | 1.44 Billion INR | 95.765% |
| Megasoft Limited | 373.95 Million INR | 83.589% |
| NATCO Pharma Limited | 40.02 Billion INR | 99.847% |
| Piramal Pharma Limited | 81.71 Billion INR | 99.925% |
| Sigachi Industries Limited | 3.98 Billion INR | 98.462% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 99.504% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 99.987% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | 99.416% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | 97.633% |
| Themis Medicare Limited | 3.81 Billion INR | 98.392% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 99.942% |
| Valiant Laboratories Limited | 1.82 Billion INR | 96.629% |
| Wanbury Limited | 5.75 Billion INR | 98.934% |
| Windlas Biotech Limited | 6.3 Billion INR | 99.027% |
| ZIM Laboratories Limited | 3.67 Billion INR | 98.33% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 99.968% |
| Ajanta Pharma Limited | 42.08 Billion INR | 99.854% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 99.521% |
| Lasa Supergenerics Limited | 1.04 Billion INR | 94.118% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | 91.877% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 99.662% |
| Alpa Laboratories Limited | 1.08 Billion INR | 94.356% |
| Gufic Biosciences Limited | 8.06 Billion INR | 99.239% |
| Ind-Swift Limited | 5.02 Billion INR | 98.779% |
| Indoco Remedies Limited | 17.89 Billion INR | 99.657% |
| Hester Biosciences Limited | 3.04 Billion INR | 97.985% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | 99.203% |
| Bajaj HealthCare Limited | 4.73 Billion INR | 98.704% |
| RPG Life Sciences Limited | 5.82 Billion INR | 98.946% |
| Mankind Pharma Limited | 103.34 Billion INR | 99.941% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 99.948% |
| Unichem Laboratories Limited | 16.57 Billion INR | 99.63% |
| Bal Pharma Limited | 3.39 Billion INR | 98.191% |
| Strides Pharma Science Limited | 40.51 Billion INR | 99.849% |
| Venus Remedies Limited | 5.91 Billion INR | 98.962% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 99.908% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 99.978% |
| Divi's Laboratories Limited | 78.45 Billion INR | 99.922% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 99.636% |
| Shilpa Medicare Limited | 11.51 Billion INR | 99.467% |
| Aarti Drugs Limited | 25.28 Billion INR | 99.757% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 99.71% |
| Suven Life Sciences Limited | 116.92 Million INR | 47.516% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 99.824% |
| Hikal Limited | 17.84 Billion INR | 99.656% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 99.467% |
| Sequent Scientific Limited | 13.69 Billion INR | 99.552% |
| Novartis India Limited | 3.35 Billion INR | 98.168% |
| Granules India Limited | 45.06 Billion INR | 99.864% |
| Wockhardt Limited | 27.89 Billion INR | 99.78% |
| Brooks Laboratories Limited | 794.86 Million INR | 92.279% |
| Neuland Laboratories Limited | 15.58 Billion INR | 99.606% |
| Morepen Laboratories Limited | 17.01 Billion INR | 99.639% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | 96.025% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | 98.335% |